Launch of a New Chemiluminescence Immunoassay Analyzer “iStar500”

-Flexibility Meets Accuracy-

Tokyo, Japan - November 17, 2023 - Medical & Biological Laboratories Co., Ltd. (CEO: Hiroki Ito), a JSR Life Sciences Company, announced today that it will release an automated mono-test chemiluminescence immunoassay (CLIA) analyzer “iStar 500” worldwide.

The iStar is a highly automated mono-test analyzer based on CLIA technology. The compact and integrated design, combined with highly sensitive CLIA technology, makes it an ideal choice for emergency diagnosis or small- to medium-sized labs looking for accurate testing results.

The bench top CLIA analyzer offers a wide range of testing parameters including cardiac markers, reproductive health, liver health, tumor markers and autoimmunity.

For cardiac biomarkers, whole blood is an analyte for measuring the markers and allows healthcare professionals to make timely and informed decisions for patients. MBL is proud to offer excellent assay performance for whole blood type cardiac biomarkers in the world with Japan quality.

iStar500-image.png
  • png

istar500-test-panels.png
  • png

Contact: 

Medical & Biological Laboratories Co., Ltd. 

Head Quarter: SUMITOMO FUDOSAN SHIBADAIMON NICHOME BLDG. 2-11-8 Shibadaimon, Minato-ku, Tokyo  105-0012  Japan 

Inquiry: https://www.mblbio.com/e/inq/ivd.html 

Contact details

Receive exclusive news

Are you a journalist or do you work for a publication?
Sign up and request access to exclusive news.

Request access

Receive JSR Life Sciences news on your RSS reader.

Or subscribe through Atom URL manually